Paul Lacaze

57PUBLICATIONS
402CO-AUTHORS
Epidemiological modellingBehavioural epidemiologyEpigenetics (incl. genome methylation and epigenomics)Cardiology (incl. cardiovascular diseases)Industrial molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (57)

|Jul 02, 2026
Identifying Risk-De-Escalating Markers in PREVENT-Defined Intermediate-Risk Older Adults: Insights From ASPREE.

|Jun 22, 2026
Inflammation and late-life depressive symptoms.

|Jun 22, 2026
A lipidomic based metabolic age score for monitoring the effects of lifestyle and diet on metabolic disease risk.

|Jun 04, 2026
The role of Lipoprotein(a) and oxidized phospholipids in modifying the effects of aspirin on major cardiovascular events and bleeding in the ASPirin in Reducing Events in the Elderly (ASPREE) randomized clinical trial: Statistical analysis plan.

|May 27, 2026
Sepsis risk associated with clonal hematopoiesis of indeterminate potential (CHIP): a secondary analysis of the ASPREE trial.

|May 08, 2026
Polygenic Risk Identifies Older Adults Who May Benefit From Aspirin for the Primary Prevention of Ischemic Stroke.

Pageof 10

Frequent Collaborators

22 joint publications

John McNeil

14 joint publications

Chenglong Yu

11 joint publications

Jane Tiller

8 joint publications

Rory Wolfe